Literature DB >> 34471254

Endothelial progenitor cells predict vascular damage progression in naive hypertensive patients according to sex.

Velia Cassano1, Giovanni Tripepi2, Maria Perticone1, Sofia Miceli1, Irene Scopacasa3, Giuseppe Armentaro1, Marta Greco4, Raffaele Maio1, Marta Letizia Hribal1, Giorgio Sesti5, Francesco Perticone1, Angela Sciacqua6.   

Abstract

Low levels of endothelial progenitor cells (EPCs) are associated with cardiovascular (CV) morbidity and mortality. Early indicators of vascular damage represent independent predictors of CV prognosis. The aim of this study was to evaluate the possible association of EPCs and circulating cytokine levels with vascular damage markers in naive hypertensive patients according to sex and to evaluate the role of EPCs in vascular damage progression. We enrolled 60 subjects; circulating EPCs were determined by cytometric analysis, and serum cytokines were determined by chemiluminescence microarray technology. Endothelial function was estimated with the measurement of the reactive hyperemia index (RHI), arterial stiffness (AS) was evaluated with the measurement of carotid-femoral pulse wave velocity (PWV) and carotid intima-media thickness (IMT) was determined by a high-resolution ultrasound B-mode system. Patients were evaluated at baseline and after an average follow-up of 3.0 ± 0.6 years. RHI was correlated with EPCs and inversely related to HOMA, TNF-α, IL-6, hs-CRP, and IL-1β. PWV was positively correlated with HOMA, TNF-α, IL-6, IL-1β, and hs-CRP, and it was inversely related to EPCs. An inverse relationship was observed between c-IMT and EPCs and e-GFR. EPCs were the major predictor of the RHI and PWV. After adjustment for vascular index basal values and the other covariates, EPCs explained 17.0%, 27.7%, and 10.6% of the variability in ΔRHI, ΔPWV, and Δc-IMT at follow-up, respectively. Our study results support the hypothesis of an etiological link between circulating EPCs and morphofunctional vascular parameters in hypertensive subjects. Of interest, circulating EPCs, after adjusting for possible confounding factors, may indicate vascular damage progression.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Arterial stiffness; Endothelial progenitor cells; Hypertension; Vascular damage

Mesh:

Year:  2021        PMID: 34471254     DOI: 10.1038/s41440-021-00716-z

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  37 in total

1.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

2.  Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.

Authors:  Francesco U S Mattace-Raso; Tischa J M van der Cammen; Albert Hofman; Nicole M van Popele; Michiel L Bos; Maarten A D H Schalekamp; Roland Asmar; Robert S Reneman; Arnold P G Hoeks; Monique M B Breteler; Jacqueline C M Witteman
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

Review 3.  Regulation of endothelial progenitor cell homing after arterial injury.

Authors:  Mihail Hristov; Alma Zernecke; Elisa A Liehn; Christian Weber
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

Review 4.  Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data.

Authors:  Alberto P Avolio; Luc M Van Bortel; Pierre Boutouyrie; John R Cockcroft; Carmel M McEniery; Athanase D Protogerou; Mary J Roman; Michel E Safar; Patrick Segers; Harold Smulyan
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

5.  Circulating endothelial progenitor cells and cardiovascular outcomes.

Authors:  Nikos Werner; Sonja Kosiol; Tobias Schiegl; Patrick Ahlers; Katrin Walenta; Andreas Link; Michael Böhm; Georg Nickenig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

6.  Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.

Authors:  Caroline Schmidt-Lucke; Lothar Rössig; Stephan Fichtlscherer; Mariuca Vasa; Martina Britten; Ulrike Kämper; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

7.  Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.

Authors:  Angela Sciacqua; Angela Scozzafava; Arturo Pujia; Raffaele Maio; Francesco Borrello; Francesco Andreozzi; Marco Vatrano; Susanna Cassano; Maria Perticone; Giorgio Sesti; Francesco Perticone
Journal:  Eur Heart J       Date:  2005-02-02       Impact factor: 29.983

8.  Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes.

Authors:  Yun-Fei Liao; Lu-Lu Chen; Tian-Shu Zeng; Yu-Ming Li; Li-Jun Hu
Journal:  Vasc Med       Date:  2010-05-28       Impact factor: 3.239

9.  Pulse pressure and endothelial dysfunction in never-treated hypertensive patients.

Authors:  Roberto Ceravolo; Raffaele Maio; Arturo Pujia; Angela Sciacqua; Giorgio Ventura; Maria C Costa; Giorgio Sesti; Francesco Perticone
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension.

Authors:  Angela Sciacqua; Raffaele Maio; Sofia Miceli; Alessandra Pascale; Giuseppe Carullo; Nadia Grillo; Franco Arturi; Giorgio Sesti; Francesco Perticone
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

View more
  1 in total

Review 1.  Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review.

Authors:  Paul Philipp Heinisch; Corina Bello; Maximilian Y Emmert; Thierry Carrel; Martina Dreßen; Jürgen Hörer; Bernhard Winkler; Markus M Luedi
Journal:  Cells       Date:  2022-05-18       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.